![](/img/cover-not-exists.png)
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
Stanley B. Cohen, Robin K. Dore, Nancy E. Lane, Peter A. Ory, Charles G. Peterfy, John T. Sharp, Désirée van der Heijde, Lifen Zhou, Wayne Tsuji, Richard NewmarkVolume:
58
Year:
2008
Language:
english
Pages:
11
DOI:
10.1002/art.23417
File:
PDF, 160 KB
english, 2008